|
Document Title:
| Thought Leader Insight & Analysis -- Hematology Q4 2009 |  |
|
Focus Area:
| Oncology and Hematology |  |
|
Specialty/Panel Description:
| Hematologists / N. America |
|
|
Publication Date:
| 01/11/2010 |
|
|
Principal Authors:
| Kim Grant, Tricia L. Hanlon, Jeffrey D. Berk, PhD, MBA |
|
|
Product Code:
| MHOQ409-22 |
|
|
Pricing:
| $7,500.00 |
|
|
Abstract:
| This report captures the opinions of 7 North American experts in malignant hematology. They provide insight into the practice-changing ramifications of the data presented at ASH 2009, relevant to multiple myeloma, myelodysplastic syndrome, acute myelogenous leukemia, chronic myelogenous leukemia and lymphoma.
|
|
|
Brochures:
| Hematology Brochure Q4 2009
|
|
|
|
Document Title:
| Thought Leader Insight & Analysis -- Multiple Myeloma/Lymphoma Q1 2009 | |
|
Focus Area:
| Multiple Myeloma/Lymphoma | |
|
Specialty/Panel Description:
| Hematologists/U.S. |
|
|
Publication Date:
| 01/21/2009 |
|
|
Principal Authors:
| Kim Grant, Tricia L. Hanlon, Jeffrey D. Berk, PhD, MBA |
|
|
Product Code:
| MHOMLQ109-16 |
|
|
Pricing:
| $7,500.00 |
|
|
Abstract:
| This report summarizes the perspectives of six renowned US Thought Leaders who specialize in multiple myeloma and lymphoma. During interviews conducted after ASH 2008, these hematologists had an opportunity to reflect on how the clinical data presented at the meeting was going to translate into changing treatment paradigms. This Panel brings together the diverse perspectives of experts who grapple with a wide spectrum of issues related to these hematologic malignancies, from clinical pathology, to community based patients, to tertiary care treatment and even medical oncology from the strategic vantage point of clinical commercial development. |
|
|
Brochures:
| MM/Lymphoma Brochure Q1 2009
|
|
|
|
Document Title:
| Thought Leader Insight & Analysis -- AML/MDS | |
|
Focus Area:
| AML/MDS | |
|
Specialty/Panel Description:
| Hematologists / N. America |
|
|
Publication Date:
| 01/09/2009 |
|
|
Principal Authors:
| Kim Grant, Tricia L. Hanlon, Jeffrey D. Berk, PhD, MBA |
|
|
Product Code:
| MHOAMQ109-18 |
|
|
Pricing:
| $7,500.00 |
|
|
Abstract:
| This report summarizes the perspectives of six renowned North American Thought Leaders specializing in acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). These interviews were all conducted within three weeks following the American Society of Hematology annual meeting that was held in San Francisco in December 2008.
This Panel was asked to highlight for us the most important data presented at the meeting, and to clarify the ways that these data will change clinical practice. A key emphasis of this Panel was transplant, and how pharmaceuticals and biologicals better prepare patients for transplant. The Panel discusses how to achieve complete responses, how they are thinking about combination therapy, and new ways for attacking quiescent malignant stem cells.
|
|
|
Brochures:
| AML/MDS Brochure Q1 2009
|
|
|
|
Document Title:
| Hematology | |
|
Focus Area:
| Major Focus: CML, MM
Supporting Coverage: MDS, AML, Mantle Cell, Follicular
| |
|
Specialty/Panel Description:
| Hematologists / N. America |
|
|
Publication Date:
| 09/10/2007 |
|
|
Principal Authors:
| Tricia L. Hanlon, Jeffrey D. Berk, PhD, MBA |
|
|
Product Code:
| MHOQ307 |
|
|
Pricing:
| $6,500.00 |
|
|
Abstract:
| Hematology/Oncology Panel #12 continues our discussion with seven Thought Leaders on the forefront of research in the management of a variety of hematologic malignancies. The major focus is chronic myelogenous leukemia and multiple myeloma. We also include insight and commentary on myelodysplastic syndrome, acute myelogenous leukemia, mantle cell and follicular lymphoma. |
|
|
Brochures:
| Hematology Brochure Q32007
|
|
|